Highlights and Quick Summary
- Shares (Common) for the quarter ending September 30, 2022 was $186 Million (a 0.29% increase compared to previous quarter)
- Year-over-year quarterly Shares (Common) increased by 1.12%
- Annual Shares (Common) for 2021 was $184 Million (a 4.22% increase from previous year)
- Annual Shares (Common) for 2020 was $177 Million (a 14.8% increase from previous year)
- Annual Shares (Common) for 2019 was $154 Million (a 39.99% increase from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shares (Common) of BioCryst Pharmaceuticals, Inc.
Most recent Shares (Common)of BCRX including historical data for past 10 years.Interactive Chart of Shares (Common) of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Shares (Common) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | $186.41 | $185.88 | $185.57 | – |
2021 | $184.35 | $179.79 | $178.73 | $177.67 | $184.35 |
2020 | $176.88 | $176.57 | $176.43 | $154.19 | $176.88 |
2019 | $154.08 | $110.44 | $110.37 | $110.27 | $154.08 |
2018 | $110.06 | $109.63 | $98.93 | $98.7 | $110.06 |
2017 | $98.41 | $98.39 | $80.43 | $80.38 | $98.41 |
2016 | $73.78 | $73.76 | $73.7 | $73.69 | $73.78 |
2015 | $73.36 | $73.34 | $73.17 | $72.47 | $73.36 |
2014 | $71.96 | $71.86 | $71.72 | $60.07 | $71.96 |
2013 | $59.09 | $59.09 | $54.2 | $51.41 | $59.09 |
2012 | $50.89 | $50.88 | $50.13 | $49.16 | $50.89 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology